Armistice Capital’s Reviva Pharmaceuticals RVPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Buy |
+2,692,000
| New | +$1.03M | 0.02% | 144 |
|
|
2025
Q1 | – | Sell |
-1,364,000
| Closed | -$2.47M | – | 271 |
|
|
2024
Q4 | $2.47M | Sell |
1,364,000
-1,822,000
| -57% | -$3.3M | 0.03% | 141 |
|
|
2024
Q3 | $4.59M | Buy |
+3,186,000
| New | +$4.59M | 0.07% | 125 |
|
|
2024
Q1 | – | Sell |
-1,764,000
| Closed | -$9.08M | – | 398 |
|
|
2023
Q4 | $9.08M | Buy |
1,764,000
+1,164,000
| +194% | +$5.99M | 0.12% | 92 |
|
|
2023
Q3 | $2.93M | Sell |
600,000
-224,000
| -27% | -$1.09M | 0.04% | 122 |
|
|
2023
Q2 | $4.83M | Buy |
+824,000
| New | +$4.83M | 0.07% | 116 |
|
|
2022
Q1 | – | Sell |
-707,578
| Closed | -$2.05M | – | 177 |
|
|
2021
Q4 | $2.05M | Buy |
707,578
+76,878
| +12% | +$222K | 0.03% | 120 |
|
|
2021
Q3 | $2.57M | Sell |
630,700
-84,000
| -12% | -$342K | 0.04% | 114 |
|
|
2021
Q2 | $3.47M | Buy |
+714,700
| New | +$3.47M | 0.06% | 97 |
|